The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Structure Therapeutics Inc.(NASDAQ:GPCR)


Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 r...
Website: https://structuretx.com
Founded: 2016
IPO Price: $15 (Feb 03, 2023)
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Structure Therapeutics Days Payable Outstanding ttm (DPO)
Structure Therapeutics Op Cashflow Per Share ttm
Structure Therapeutics Free Cashflow Per Share ttm
Structure Therapeutics Cash Per Share ttm
Structure Therapeutics (GAAP) P/E ratio ttm
Structure Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.